Details for Patent: 9,421,333
✉ Email this page to a colleague
Which drugs does patent 9,421,333 protect, and when does it expire?
Patent 9,421,333 protects OTREXUP and is included in one NDA.
This patent has twelve patent family members in seven countries.
Summary for Patent: 9,421,333
Title: | Hazardous agent injection system |
Abstract: | Injection systems comprising a powered injector and one or more hazardous agents are disclosed. |
Inventor(s): | Wotton; Paul K. (Newton, PA), Sadowski; Peter L. (Woodbury, MN), Hayes; John W. (Chaska, MN) |
Assignee: | Antares Pharma, Inc. (Ewing, NJ) |
Application Number: | 14/582,411 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 9,421,333
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otter Pharms | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-005 | Nov 7, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | ⤷ Try a Trial | |||
Otter Pharms | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-001 | Oct 11, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | ⤷ Try a Trial | |||
Otter Pharms | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-006 | Mar 24, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | ⤷ Try a Trial | |||
Otter Pharms | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-002 | Oct 11, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | ⤷ Try a Trial | |||
Otter Pharms | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-007 | Mar 24, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,421,333
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010226442 | ⤷ Try a Trial | |||
Canada | 2755779 | ⤷ Try a Trial | |||
China | 102612381 | ⤷ Try a Trial | |||
European Patent Office | 2408493 | ⤷ Try a Trial | |||
Japan | 2012521224 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |